Discover 1,106 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Filter
1
Filter results
Results: 1,106
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
for
PPAP, Spine Fusion
Location: Pittsburgh PA, Indianapolis IN, San Francisco CA
Sponsor: Senthil Sadhasivam
Sex: All
Age: 10 - 21
Code: NCT05367609
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
for
Type 1 Diabetes, Obesity
Location: Indianapolis IN
Sponsor: Heba M. Ismail
Sex: All
Age: 11 - 18
Code: NCT05414409
Phase2, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Bridgeport CT, The Bronx NY, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase3, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, New York NY, Paramus NJ, Bethlehem PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trial-Ready Cohort-Down Syndrome (TRC-DS)
for
Down Syndrome, Alzheimer Disease, Dementia
Location: Boston MA, Staten Island NY, Pittsburgh PA,
Sponsor: University of Southern California
Sex: All
Age: 25 - 55
Code: NCT04165109
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Providence RI, New Haven CT, New York NY, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase1, Phase2, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: Boston MA, Philadelphia PA, Fairfax VA, Detroit MI,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase1, Phase2, Recruiting
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
for
Neoplasm, Colorectal, Cognitive Impairment,
Location: Fort Wayne IN
Sponsor: Joseph McCollom
Sex: All
Age: 18+
Code: NCT05014399
Recruiting
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
for
Carotid Artery Diseases
Location: New York NY, Rochester NY, Cincinnati OH,
Sponsor: InspireMD
Sex: All
Age: 18 - 70+
Code: NCT06653387
Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Farmington CT, New York NY, Philadelphia PA,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase2, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection